arrow_back Back Filing freshness 10-Q Q3 FY2026 SEC EDGAR

PFIZER INC

PFE
$29.91 ▼ -0.88 (-2.86%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
76 Visible periods
30 Metrics
Peer-ranked Benchmarks
Price Chart
61
Health
Fair
Neutral
auto_awesome

Analytical Summary

PFIZER INC shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $170.5B
Dividend Yield —
Revenue Growth -0.4% ↘
Op. Margin —
ROIC —
FCF / Share $0.84 ↗
Trailing P/E 52.5x
Price / Book 1.9x
FCF Yield 2.8%
Debt / Equity 0.67
info Valuation on last close. End-of-day price, Nov 5, 2026.

76-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$16.58B
— -0.4% —
Net Income Profit after all expenses
$3.24B
↓ -8.4% —
FCF / Share Free cash flow per share
$0.84
↑ +1489.8% —
Long-Term Debt Long-term obligations
$60.00B
↓ -0.8% —

Health Breakdown

Profitability ↓
70
Returns ↓
64
Financial Health ↑
39
Cash Quality ↓
72

Dividend History

Dividend / share · sourced from SEC filings
$1.72 Latest / share
+1.8% YoY
+4.7% 12-yr CAGR

bar_chart Data from SEC EDGAR XBRL filings

Synced 5 days ago 20 years · 76 quarters